Literature DB >> 22332716

The dynamic determinants of reaction specificity in the IMPDH/GMPR family of (β/α)(8) barrel enzymes.

Lizbeth Hedstrom1.   

Abstract

The inosine monophosphate dehydrogenase (IMPDH)/guanosine monophosphate reductase (GMPR) family of (β/α)(8) enzymes presents an excellent opportunity to investigate how subtle changes in enzyme structure change reaction specificity. IMPDH and GMPR bind the same ligands with similar affinities and share a common set of catalytic residues. Both enzymes catalyze a hydride transfer reaction involving a nicotinamide cofactor hydride, and both reactions proceed via the same covalent intermediate. In the case of IMPDH, this intermediate reacts with water, while in GMPR it reacts with ammonia. In both cases, the two chemical transformations are separated by a conformational change. In IMPDH, the conformational change involves a mobile protein flap while in GMPR, the cofactor moves. Thus reaction specificity is controlled by differences in dynamics, which in turn are controlled by residues outside the active site. These findings have some intriguing implications for the evolution of the IMPDH/GMPR family.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22332716      PMCID: PMC3337344          DOI: 10.3109/10409238.2012.656843

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  94 in total

1.  SCOP database in 2002: refinements accommodate structural genomics.

Authors:  Loredana Lo Conte; Steven E Brenner; Tim J P Hubbard; Cyrus Chothia; Alexey G Murzin
Journal:  Nucleic Acids Res       Date:  2002-01-01       Impact factor: 16.971

2.  Adaptive evolution of drug targets in producer and non-producer organisms.

Authors:  Bjarne G Hansen; Xin E Sun; Hans J Genee; Christian S Kaas; Jakob B Nielsen; Uffe H Mortensen; Jens C Frisvad; Lizbeth Hedstrom
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

3.  Inactivation of guanosine 5'-phosphate reductase by 6-chloro-, 6-mercapto-, and 2-amino-6-mercapto-9-beta-D-ribofuranosylpurine 5'-phosphates.

Authors:  L W Brox; A Hampton
Journal:  Biochemistry       Date:  1968-01       Impact factor: 3.162

4.  Molecular cloning and characterisation of the gua regulatory region of Escherichia coli K12.

Authors:  M S Thomas; W T Drabble
Journal:  Mol Gen Genet       Date:  1984

5.  Kinetic mechanism of human inosine 5'-monophosphate dehydrogenase type II: random addition of substrates and ordered release of products.

Authors:  W Wang; L Hedstrom
Journal:  Biochemistry       Date:  1997-07-15       Impact factor: 3.162

6.  Allosteric activation via kinetic control: potassium accelerates a conformational change in IMP dehydrogenase.

Authors:  Thomas V Riera; Lianqing Zheng; Helen R Josephine; Donghong Min; Wei Yang; Lizbeth Hedstrom
Journal:  Biochemistry       Date:  2011-09-09       Impact factor: 3.162

7.  The Cys319 loop modulates the transition between dehydrogenase and hydrolase conformations in inosine 5'-monophosphate dehydrogenase.

Authors:  Helen R Josephine; Kanchana R Ravichandran; Lizbeth Hedstrom
Journal:  Biochemistry       Date:  2010-11-23       Impact factor: 3.162

8.  Crystal structures of Tritrichomonasfoetus inosine monophosphate dehydrogenase in complex with substrate, cofactor and analogs: a structural basis for the random-in ordered-out kinetic mechanism.

Authors:  Glen L Prosise; Hartmut Luecke
Journal:  J Mol Biol       Date:  2003-02-14       Impact factor: 5.469

9.  IMP dehydrogenase type 1 associates with polyribosomes translating rhodopsin mRNA.

Authors:  Sarah E Mortimer; Dong Xu; Dharia McGrew; Nobuko Hamaguchi; Hoong Chuin Lim; Sara J Bowne; Stephen P Daiger; Lizbeth Hedstrom
Journal:  J Biol Chem       Date:  2008-10-30       Impact factor: 5.157

10.  Characterization of human type I and type II IMP dehydrogenases.

Authors:  S F Carr; E Papp; J C Wu; Y Natsumeda
Journal:  J Biol Chem       Date:  1993-12-25       Impact factor: 5.157

View more
  7 in total

Review 1.  Molecular Mechanisms of Enzyme Activation by Monovalent Cations.

Authors:  David W Gohara; Enrico Di Cera
Journal:  J Biol Chem       Date:  2016-07-26       Impact factor: 5.157

2.  The cystathionine-β-synthase domains on the guanosine 5''-monophosphate reductase and inosine 5'-monophosphate dehydrogenase enzymes from Leishmania regulate enzymatic activity in response to guanylate and adenylate nucleotide levels.

Authors:  Sabrina Smith; Jan Boitz; Ehzilan Subramanian Chidambaram; Abhishek Chatterjee; Maria Ait-Tihyaty; Buddy Ullman; Armando Jardim
Journal:  Mol Microbiol       Date:  2016-03-10       Impact factor: 3.501

3.  A purine metabolic checkpoint that prevents autoimmunity and autoinflammation.

Authors:  Svetlana Saveljeva; Gavin W Sewell; Katharina Ramshorn; M Zaeem Cader; James A West; Simon Clare; Lea-Maxie Haag; Rodrigo Pereira de Almeida Rodrigues; Lukas W Unger; Ana Belén Iglesias-Romero; Lorraine M Holland; Christophe Bourges; Muhammad N Md-Ibrahim; James O Jones; Richard S Blumberg; James C Lee; Nicole C Kaneider; Trevor D Lawley; Allan Bradley; Gordon Dougan; Arthur Kaser
Journal:  Cell Metab       Date:  2022-01-04       Impact factor: 27.287

4.  Expanding Benzoxazole-Based Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure-Activity As Potential Antituberculosis Agents.

Authors:  Shibin Chacko; Helena I M Boshoff; Vinayak Singh; Davide M Ferraris; Deviprasad R Gollapalli; Minjia Zhang; Ann P Lawson; Michael J Pepi; Andrzej Joachimiak; Menico Rizzi; Valerie Mizrahi; Gregory D Cuny; Lizbeth Hedstrom
Journal:  J Med Chem       Date:  2018-05-30       Impact factor: 7.446

5.  Degradation of brown adipocyte purine nucleotides regulates uncoupling protein 1 activity.

Authors:  Tobias Fromme; Karin Kleigrewe; Andreas Dunkel; Angelika Retzler; Yongguo Li; Stefanie Maurer; Natascha Fischer; Rolf Diezko; Timo Kanzleiter; Verena Hirschberg; Thomas Hofmann; Martin Klingenspor
Journal:  Mol Metab       Date:  2017-12-26       Impact factor: 7.422

6.  Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration.

Authors:  Guan Wang; Jérôme Durussel; Jonathan Shurlock; Martin Mooses; Noriyuki Fuku; Georgie Bruinvels; Charles Pedlar; Richard Burden; Andrew Murray; Brendan Yee; Anne Keenan; John D McClure; Pierre-Edouard Sottas; Yannis P Pitsiladis
Journal:  BMC Genomics       Date:  2017-11-14       Impact factor: 3.969

7.  Novel Characteristics of Trypanosoma brucei Guanosine 5'-monophosphate Reductase Distinct from Host Animals.

Authors:  Tomoaki Bessho; Tetsuya Okada; Chihiro Kimura; Takahiro Shinohara; Ai Tomiyama; Akira Imamura; Mitsuru Kuwamura; Kazuhiko Nishimura; Ko Fujimori; Satoshi Shuto; Osamu Ishibashi; Bruno Kilunga Kubata; Takashi Inui
Journal:  PLoS Negl Trop Dis       Date:  2016-01-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.